ArchivesMagazine - 05 May 20222022 should prove a pivotal year for GlaxoSmithKline The company will soon demerge its consumer healthcare arm, Haleon 05 May 2022|Great Ideas Issue: 05 May 2022 - Page 12 < Shares in comparison website owner Moneysupermarket are too cheap to ignore Why we’re sticking with formidable long-run performer Fidelity Special Values > Issue: 05 May 2022 - Page 12 | Contents Next: Why we’re sticking with formidable long-run performer Fidelity Special Values Previous: Shares in comparison website owner Moneysupermarket are too cheap to ignore Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Martin Gamble Issue Contents Ask Tom Is my employer playing tricks with my pension? Editor's View Reasons why Amazon is not a great investment at the current price Feature Big tech earnings: the lowdown on Alphabet, Amazon, Apple, Meta and Microsoft Why now is a great time to look at ultra-cheap shares The CEOs making investors rich: The FTSE 100 bosses behind the biggest returns The challenges now facing the big digital advertising players Google and Facebook Great Ideas Find out why WH Smith remains an exciting Covid recovery play A tight power market continues to drive earnings upgrades at Drax Why we’re sticking with formidable long-run performer Fidelity Special Values 2022 should prove a pivotal year for GlaxoSmithKline Shares in comparison website owner Moneysupermarket are too cheap to ignore This is how to find a winning combination of cheap stocks and inflation protection Investment Trusts This little known investment trust has turned £5 million into £740 million News UK bank shares hit by concerns over the economy Tesla shareholders are the losers from Elon Musk’s plan to buy Twitter BP’s best underlying profit in a decade will only add to windfall tax calls Personal Finance How different versions of the same fund get taxed Russ Mould Japan shock: Why the yen’s plunge really matters